Proteomics Market Surges Toward US$ 85.91 Billion by 2031: Trends, Innovations, and Regional Insights

United States of America – January 12, 2025 – According to The Insight Partners, the proteomics market size is projected to surge from US$ 34.56 billion in 2024 to US$ 85.91 billion by 2031; the market is estimated to record a CAGR of 11.9% during 2025-2031. The proteomics market continues to evolve rapidly, driven by innovations in protein analysis technologies that support precision medicine and drug development worldwide. Leading companies in the proteomics field are advancing tools for clinical diagnostics and research, positioning the sector for sustained expansion through 2031.​

Get a Sample Copy At - https://www.theinsightpartners.com/sample/TIPHE100001115/

Market Overview

Proteomics involves the large-scale study of proteins, including their structures, functions, and interactions within biological systems. This field plays a crucial role in understanding disease mechanisms, identifying biomarkers, and accelerating therapeutic discoveries. Recent advancements, such as AI-driven protein analysis and high-throughput instrumentation, have made proteomics indispensable for pharmaceutical and biotechnology companies.​

The market spans key segments including instrumentation technologies, reagents and consumables, and software & services. Applications focus on clinical diagnostics and drug discovery & development, serving end users like pharmaceutical & biotechnology companies, research & clinical laboratories, and hospitals. These elements fuel growth as researchers tackle complex challenges in personalized healthcare.​

Market Size, Share, Trends, Analysis, and Forecast by 2031

• Global Market Size and Growth: The proteomics market stood at US$ 34.56 billion in 2024 and is projected to reach US$ 85.91 billion by 2031, reflecting a compound annual growth rate (CAGR) of 11.9% from 2025 to 2031.​
• Market Share by Segments: Reagents & consumables command the largest share due to high demand in research settings, while clinical diagnostics leads applications, driven by biomarker identification needs.​
• Key Trends: Integration of AI and automation enhances protein profiling accuracy; next-generation sequencing compatibility boosts throughput; rising focus on multi-omics convergence combines proteomics with genomics for deeper insights.​
• Market Analysis: Growth stems from surging chronic disease prevalence, like cancer and cardiovascular conditions, increasing demand for protein-based diagnostics and personalized therapies.​
• Forecast Drivers: Expanded R&D investments and regulatory support for proteomics in precision medicine will propel expansion, with software & services gaining traction for data analysis.​

Global and Regional Analysis

North America dominates the proteomics market, holding the largest share thanks to robust R&D funding, advanced infrastructure, and a concentration of pharmaceutical giants. Europe follows closely, supported by collaborative research initiatives and strong biotech ecosystems.​

Asia Pacific emerges as the fastest-growing region, with countries like China and India benefiting from expanding pharma manufacturing, rising investments, and a large patient population for clinical studies. Latin America, Middle East, and Africa show potential through increasing healthcare access and partnerships.​

Updated Market News

In 2025, Illumina acquired SomaLogic for up to $425 million, integrating aptamer-based proteomics into NovaSeq sequencing workflows to enable simultaneous genetic and protein analysis. This moves underscores multi-omics trends and strengthens high-throughput capabilities.​

Proteome Sciences announced its 2024 results release in April 2025, highlighting ongoing advancements in its TMT mass tagging technology for quantitative proteomics. Meanwhile, companies like Nautilus Biotechnology progress toward single-molecule platforms, targeting launches in late 2025 or 2026.​

Recent collaborations, such as SomaLogic and Illumina's joint development, accelerate proteomics in drug discovery. These developments reflect a dynamic landscape where innovation meets clinical needs.​

Key Company Profiles

Proteome Sciences leads with innovative mass spectrometry tools for biomarker discovery. Biognosys excels in next-generation proteomics for deep proteome coverage.​

Creative Proteomics offers comprehensive services across instrumentation and custom assays. Shantani focuses on advanced protein analytics for research applications.​

Olink provides proximity extension assay technology for high-sensitivity protein detection. SomaLogic Operating Co., Inc. pioneer’s aptamer-based platforms, now enhanced by Illumina integration.​

QUANTUM-SI INCORPORATED advances single-molecule protein sequencing. Proteomics International develops diagnostics like PromarkerD for kidney disease.​

Promise Proteomics and SCIEX contribute with cutting-edge software and mass spectrometry solutions, supporting global research efforts.​

Purchasing This Report? Click Here At - https://www.theinsightpartners.com/buy/TIPHE100001115/

If you have any special requirements about this Proteomics Market report, please let us know and we can provide custom report.

About the Proteomics Sector

The proteomics market thrives on technological convergence and real-world applications that transform healthcare. Stakeholders from pharma to academia leverage these tools for breakthroughs in diagnostics and therapy. As trends like AI integration and regional expansions unfold, the field promises broader impact by 2031.​

Related Reports

• Mass Spectrometry Market Outlook, Segments, Recent Developments, and Insights by 2031
• Mass Spectrometry Software Market Key Players and Forecast by 2027
• Recombinant Proteins Market Dynamics and Developments by 2031
• Protein Expression Market Growth and Analysis by 2028
• Genomics Market Dynamics and Developments by 2031

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us

If you have any questions about this report or if you would like further information, please get in touch with us:

Contact Person: Ankit Mathur

Email: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in: 日本| 한국어 | French | لعربية< |中文| Italian | Spanish | Deutsch